How Do We Provide HCV Care for Individuals Experiencing Homelessness?
Registration |
---|
You must log in or create an account before enrolling in this educational activity. Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Target Audience
Providers and clinical staff who are interested in providing treatment and care to individuals diagnosed with Hepatitis C (providers, nursing, behavioral health, linkage navigators, front desk/scheduling, admin, etc.).
Learning Objectives
- Explore unique challenges to HCV treatment implementation for individuals experiencing homelessness.
- Provide practical solutions for successful engagement in HCV care for this population.
Speaker
Marguerite Beiser, ANP-BC
Director, Hepatitis C Services
Maggie Beiser is an adult nurse practitioner who has worked at Boston Health Care for the Homeless Program since 2008. She provides adult primary care and specialty care to patients living with HIV infection and has been certified as an HIV Specialist by the American Academy of HIV Medicine since 2010.
In 2014 she developed and implemented a primary care-based hepatitis C (HCV) treatment program which has treated over 900 individuals. She currently administers that program as the Director of HCV Services and participates in HCV education, treatment advocacy, and policy planning at local, state and national levels. Recent and ongoing research projects focus on describing the outcomes of HCV treatment for homeless and unstably housed adults to advance the goal of elimination of HCV among our disproportionately affected patient population.
Terms of Use and Privacy Policy
Recording date: May 18, 2021
Date of original release: July 12, 2021
Most recent review/update: July 12, 2021
Termination date: July 11, 2024
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.75 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This live activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Julie Baker, MPH, CHCEF - Planning Committee Member and Moderator
- Sarah Dixon, MPA - Planning Committee Member
- Steven Donnelly, PharmD - Planning Committee Member
- Alicia Huguelet, MPH, MSW - Planning Committee Member
- Gagandeep Lamba, MA, MS, MBA, CSM - Activity Planning Committee Member
- Bethany Maen - Planning Committee Member
- Chelsea Miller - Planning Committee Member
- Liz Noble - Planning Committee Member
- Kristi Roose, BA, CPHIMS - Planning Committee Member
- Megan Srinivas, MD, MPH - Planning Committee Member
- Megan Westerly, MSN, BA, RN - Moderator
- Marguerite Beiser, ANP-BC - Speaker
Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with ineligible companies to disclose. All financial relationships have been mitigated by the accredited provider.
- Donald Hillebrand, MD - Planning Committee Member, Speaker’s bureau for AbbVie and Gilead
- Mark Hillenbrand, LISW, RCSW - Planning Committee Member and Speaker, Spouse is an employee at Vida Health (develops health information material for consumers)
Disclaimer
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 0.75 AMA PRA Category 1 Credits™
- 0.75 AOA Category 2B
- 0.75 CE Contact Hour(s)